These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21423852)

  • 21. Resistant trichomoniasis: successful treatment with combination therapy.
    Nyirjesy P; Gilbert J; Mulcahy LJ
    Sex Transm Dis; 2011 Oct; 38(10):962-3. PubMed ID: 21934573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding.
    Kissinger P; Amedee A; Clark RA; Dumestre J; Theall KP; Myers L; Hagensee ME; Farley TA; Martin DH
    Sex Transm Dis; 2009 Jan; 36(1):11-6. PubMed ID: 19008776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative study of genotoxic effects in the treatment of trichomonas vaginalis infection: metronidazole or nalidixic acid.
    Akyol D; Mungan T; Baltaci V
    Arch Gynecol Obstet; 2000 Jul; 264(1):20-3. PubMed ID: 10985613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized trial of intravaginal nonoxynol 9 versus oral metronidazole in the treatment of vaginal trichomoniasis.
    Antonelli NM; Diehl SJ; Wright JW
    Am J Obstet Gynecol; 2000 May; 182(5):1008-10. PubMed ID: 10819810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Managing vaginal trichomoniasis resistant to high-dose metronidazole therapy.
    Lewis DA; Habgood L; White R; Barker KF; Murphy SM
    Int J STD AIDS; 1997 Dec; 8(12):780-4. PubMed ID: 9433954
    [No Abstract]   [Full Text] [Related]  

  • 26. Probiotics in addition to metronidazole for treatment Trichomonas vaginalis in the presence of BV: a randomized, placebo-controlled, double-blind study.
    Sgibnev A; Kremleva E
    Eur J Clin Microbiol Infect Dis; 2020 Feb; 39(2):345-351. PubMed ID: 31705339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population.
    Krashin JW; Koumans EH; Bradshaw-Sydnor AC; Braxton JR; Evan Secor W; Sawyer MK; Markowitz LE
    Sex Transm Dis; 2010 Jul; 37(7):440-4. PubMed ID: 20351623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Updates in trichomonas treatment including persistent infection and 5-nitroimidazole hypersensitivity.
    Muzny CA; Van Gerwen OT; Kissinger P
    Curr Opin Infect Dis; 2020 Feb; 33(1):73-77. PubMed ID: 31789671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does Antiretroviral Therapy Interfere With the Treatment of Trichomonas vaginalis Among HIV+ Women?
    Kissinger P; Adamski A; Clark RA; Mena L; Levison J; Martin DH
    Sex Transm Dis; 2013 Jun; 40(6):506-7. PubMed ID: 23677024
    [No Abstract]   [Full Text] [Related]  

  • 30. Alternative drugs against Trichomonas vaginalis.
    Mahdi NK; Gany ZH; Sharief M
    East Mediterr Health J; 2006 Sep; 12(5):679-84. PubMed ID: 17333809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trichomoniasis and its treatment.
    Nanda N; Michel RG; Kurdgelashvili G; Wendel KA
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):125-35. PubMed ID: 16441214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pilot study of metronidazole vaginal gel versus oral metronidazole for the treatment of Trichomonas vaginalis vaginitis.
    duBouchet L; McGregor JA; Ismail M; McCormack WM
    Sex Transm Dis; 1998 Mar; 25(3):176-9. PubMed ID: 9524997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-Trichomonas vaginalis activity of ursolic acid derivative: a promising alternative.
    Bitencourt FG; de Brum Vieira P; Meirelles LC; Rigo GV; da Silva EF; Gnoatto SCB; Tasca T
    Parasitol Res; 2018 May; 117(5):1573-1580. PubMed ID: 29572567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trichomonas vaginalis and growing concern over drug resistance: a systematic review.
    Marques-Silva M; Lisboa C; Gomes N; Rodrigues AG
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):2007-2021. PubMed ID: 34146427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of metronidazole-resistant Trichomonas vaginalis in pregnancy.
    Forbes GL; Drayton R; Forbes GD
    Int J STD AIDS; 2016 Sep; 27(10):906-8. PubMed ID: 26384945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel metronidazole-chalcone conjugates with potential to counter drug resistance in Trichomonas vaginalis.
    Anthwal A; Rajesh UC; Rawat MS; Kushwaha B; Maikhuri JP; Sharma VL; Gupta G; Rawat DS
    Eur J Med Chem; 2014 May; 79():89-94. PubMed ID: 24727243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trichomoniasis and HIV interactions: a review.
    Kissinger P; Adamski A
    Sex Transm Infect; 2013 Sep; 89(6):426-33. PubMed ID: 23605851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal Timing for Trichomonas vaginalis Test of Cure Using Nucleic Acid Amplification Testing.
    Craig-Kuhn MC; Granade C; Muzny CA; Van Der Pol B; Lillis R; Taylor SN; Schmidt N; Martin DH; Kissinger P
    Sex Transm Dis; 2019 May; 46(5):312-316. PubMed ID: 30601374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activity of nitazoxanide against some metronidazole-resistant and susceptible Trichomonas vaginalis isolates.
    Abdel-Magied AA; Hammouda MM; Mosbah A; El-Henawy AA
    J Infect Chemother; 2017 Apr; 23(4):230-233. PubMed ID: 28131737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment Attitudes for Belgian Women With Persistent Trichomonas vaginalis Infection in the VlaResT Study.
    Donders GGG; Ruban K; Depuydt C; Bellen G; Vanden Broeck D; Jonckheere J; Jacquemyn Y
    Clin Infect Dis; 2019 Apr; 68(9):1575-1580. PubMed ID: 30395193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.